First Patient of Cohort 2 Dosed in MND Trial 3 market sensitive
First Patient of Cohort 2 Dosed in MND Trial (final)
PharmAust canine trial update 18 market sensitive
PharmAust canine trial update Feb (final)
Appendix 4C and Quarterly Update
Appendix 4C and Quarterly Update – Dec 22
PharmAust Progresses to Elevated Doses in MND Patients
PharmAust Progresses to Elevated Doses of MPL in MND Patients
Fireside chat with Dr Roger Aston
https://pharmaust.com/wp-content/uploads/2023/01/Fireside-chat-with-Roger.mp4
MND Trial Successfully Completes First Patient Cohort
MND Trial Completes Enrolment of First Patient Cohort (final)